The Biden administration is calling on COVID-19 vaccine makers to ensure the updated shots for the fall are priced affordably.
“Updated COVID-19 vaccines entering the market this fall should be priced at a reasonable rate, reflective of the value that you have obtained through U.S. government investment,” Health and Human Services Secretary Xavier Becerra said in a Thursday letter to the CEOs of Pfizer, Moderna and Novavax.
“Price gouging behavior takes advantage of the trust the American people have placed in you through the COVID-19 response,” Becerra said.